To determine whether drebrin also plays a role in prostate cancer cell motility, PC-3 cells were plated into 6-well dishes coated with fibronectin and imaged by phase contrast microscopy in the presence of DMSO (vehicle control) or different concentrations of BTP2 to inhibit drebrin binding to F-actin. Here, FN1 is linked to prostate cancer.